Literature DB >> 17910205

Pharmacologic treatment of autism and related disorders.

Craig A Erickson1, David J Posey, Kimberly A Stigler, Christopher J McDougle.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17910205     DOI： 10.3928/0090-4481-20070901-09

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN： 0090-4481            Impact factor:   1.132


× No keyword cloud information.
  11 in total

1.  Paliperidone palmitate in a child with autistic disorder.

Authors:  Janet L Kowalski; Logan K Wink; Kelly Blankenship; Cheryl D Habenicht; Craig A Erickson; Kimberly A Stigler; Christopher J McDougle
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-10       Impact factor: 2.576

Review 2.  Aripiprazole in autism spectrum disorders and fragile X syndrome.

Authors:  Craig A Erickson; Kimberly A Stigler; David J Posey; Christopher J McDougle
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

3.  Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.

Authors:  Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius Dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock
Journal:  Psychopharmacology (Berl)       Date:  2021-06-05       Impact factor: 4.530

Review 4.  Autism, fever, epigenetics and the locus coeruleus.

Authors:  Mark F Mehler; Dominick P Purpura
Journal:  Brain Res Rev       Date:  2008-11-24

5.  Body mass index change in autism spectrum disorders: comparison of treatment with risperidone and aripiprazole.

Authors:  Logan K Wink; Maureen Early; Tori Schaefer; Amy Pottenger; Paul Horn; Christopher J McDougle; Craig A Erickson
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-02-24       Impact factor: 2.576

Review 6.  Pharmacotherapy of Disruptive Behaviors in Children with Intellectual Disabilities.

Authors:  Gabrielle E Hodgins; Kristen Winsor; Jarrett Barnhill
Journal:  Paediatr Drugs       Date:  2022-07-04       Impact factor: 3.930

7.  Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder.

Authors:  Logan K Wink; Ernest V Pedapati; Ryan Adams; Craig A Erickson; Kahsi A Pedersen; Eric M Morrow; Desmond Kaplan; Matthew Siegel
Journal:  J Autism Dev Disord       Date:  2018-11

8.  Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.

Authors:  Sarah L Logan; Laura Carpenter; R Scott Leslie; Elizabeth Garrett-Mayer; Kelly J Hunt; Jane Charles; Joyce S Nicholas
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

Review 9.  Advances in the treatment of fragile X syndrome.

Authors:  Randi J Hagerman; Elizabeth Berry-Kravis; Walter E Kaufmann; Michele Y Ono; Nicole Tartaglia; Ave Lachiewicz; Rebecca Kronk; Carol Delahunty; David Hessl; Jeannie Visootsak; Jonathan Picker; Louise Gane; Michael Tranfaglia
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

Review 10.  Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children.

Authors:  Gregory L Holmes
Journal:  Paediatr Drugs       Date:  2020-11-24       Impact factor: 3.022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.